Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services.

Jeannon JP; Abbs I; Calman F; Gleeson M; Lyons A; Hussain K; McGurk M; OConnell M; Probert D; Ng R; Simo R

首页> 外文期刊>Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery >Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services.

【24h】

Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services.

机译：实施美国国家临床卓越研究所，以改善头颈癌的治疗结局：通过重组头颈癌服务制定业务计划。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The implementation of the National Institute of Clinical Excellence improving outcome guidelines (NICE-IOG) manual for head and neck cancer may have a huge potential cost implication. Head and neck cancer is a rare disease which utilises large quantities of resources which can only be provided in a tertiary centre. Head and neck cancer services should be centralised into a single site for each cancer network. A new higher tariff rate for complex head and neck cancer cases is needed which recognises the true cost of this work. Each network should set its own tariff to make head and neck cancer care financially viable. Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

机译：美国国家临床卓越研究所改善头颈癌预后指南（NICE-IOG）手册的实施可能具有巨大的潜在成本隐患。头颈癌是一种罕见的疾病，它利用大量资源，而这些资源只能在第三中心提供。头颈部癌症服务应集中到每个癌症网络的单个站点中。需要为复杂的头颈癌病例制定新的更高的关税税率，以承认这项工作的真正成本。每个网络都应设置自己的费率，以使头颈癌治疗在财务上可行。荷兰耳鼻喉和颈面部外科学会

著录项

来源
《Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery》 |2008年第2期|共3页
作者
Jeannon JP; Abbs I; Calman F; Gleeson M; Lyons A; Hussain K; McGurk M; OConnell M; Probert D; Ng R; Simo R;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类耳鼻咽喉科学;
关键词
Head and Neck Cancer; guiding characteristics; Clinical; Malignant Neoplasms;

机译：头颈癌;指导特征;临床;恶性肿瘤;

相似文献

外文文献
中文文献
专利

1. Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services. [J] . Jeannon JP, Abbs I, Calman F, Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery . 2008,第2期

机译：实施美国国家临床卓越研究所，以改善头颈癌的治疗结局：通过重组头颈癌服务制定业务计划。
2. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia [J] . AdelsteinD.J., RidgeJ.A., BrizelD.M., Head and neck: Journal for the sciences and specialities of the head and neck . 2012,第12期

机译：经咽喉咽癌切除术：美国国家癌症研究所头颈癌指导委员会临床试验计划会议摘要，2011年11月6日至7日，弗吉尼亚州阿灵顿
3. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). [J] . Bjarnason GA, Mackenzie RG, Nabid A, International Journal of Radiation Oncology, Biology, Physics . 2009,第1期

机译：头颈癌患者清晨和傍晚放疗相关毒性的比较：加拿大国家癌症研究所临床试验组（HN3）的一项前瞻性随机试验。
4. Immediate and Late Clinical Outcomes in Patients with Head and Neck Cancer Treated at the Ural Neutron Center [C] . KUZNETSOVA Anna, VAZHENIN Andrey, GOLYKOV Oleg, International Conference on Physical-Technical Problems of Nuclear Science, Energy Generation and Power Industry . 2015

机译：在尿布中子中心治疗头部和颈部癌症患者的立即和晚期临床结果
5. National and Institutional Outcomes Data in Head and Neck Cancers, and Functional and Patient Reported Outcomes in Patients with Oropharyngeal Cancers. [D] . Kansal, Ankit. 2017

机译：头颈癌的国家和机构结局数据，以及口咽癌患者的功能和患者报告结局。
6. Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting [O] . Julie E. Bauman, Ezra Cohen, Robert L. Ferris, -1

机译：头颈癌的免疫疗法：国家癌症研究所头颈癌指导委员会规划会议的新临床试验
7. Clinical analysis for head and neck cancer cases treated with nivolumab in Osaka International Cancer Institute [O] . Tomoyuki Otsuka, Takayuki Kimura, Ryosuke Koike, 2019

机译：大阪中幼虫病治疗头颈癌病例的临床分析

Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services.

摘要

著录项

相似文献

相关主题

期刊订阅